FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

424919009: Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Mar 2022. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    3679328019 Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3679329010 Glimepiride 4 mg and pioglitazone hydrochloride 30 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    108431501000001119 Glimepiride 4 mg and pioglitazone 30 mg oral tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Is a Product containing glimepiride and pioglitazone false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has active ingredient Glimepiride false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has active ingredient Thiazolidinedione false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has active ingredient Pioglitazone false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has active ingredient Pioglitazone hydrochloride false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has active ingredient Glimepiride false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has basis of strength substance Glimepiride false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has presentation strength numerator value 4 false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has active ingredient Pioglitazone hydrochloride false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has basis of strength substance Pioglitazone hydrochloride false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has presentation strength numerator value 30 false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has precise active ingredient Pioglitazone hydrochloride false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has precise active ingredient Glimepiride false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Is a Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Is a Product containing only glimepiride and pioglitazone in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has precise active ingredient Glimepiride false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has basis of strength substance Pioglitazone hydrochloride false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has precise active ingredient Pioglitazone hydrochloride false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has basis of strength substance Glimepiride false Inferred relationship Existential restriction modifier 2

    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start